COR2ED Medical Education

3

March 27, 2023 • 00:22:49

Overview of efficacy and safety data of combination therapy with PARPi and NHAs

Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment...

1

March 14, 2023 • 00:24:54

Advanced HCC and not eligible for IO – what are the treatment options?

COR2ED Medical Education: Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist...

2

February 15, 2023 • 00:19:43

PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective

COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...

1

February 15, 2023 • 00:21:50

Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective

COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...

2

February 08, 2023 • 00:28:03

The nurses’ perspective: Systemic therapy in endometrial carcinoma

Medical education: Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects...

1

February 08, 2023 • 00:29:25

The physicians’ perspective: Systemic therapy in endometrial carcinoma

Medical education: Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment...